Statistical analysis of microarray experiments
The development of gene expression array (microarray) technology has introduced the opportunity to study, on a genome-wide scale and in systematic fashion, how the information statically coded in DNA translates to the dynamics of cell life. The scientific community's sizeable interest in this line of research has spurred development of statistical methodologies to analyze the data appropriately; since initial contributions appearing in 2000, there has been a growing body of statistical literature devoted to their analysis. There are a variety of questions in this area that statistics can help address; in the present work we limit our consideration to the analysis of datasets obtained comparing transcription levels of genes in cells grown in a baseline condition to those in cells representing one experimental condition of interest (for example, a specific growth media, a cell line where a gene has been knocked out, or a cancerous cell line). In such experiments-which can be conducted both with single-channel as well as two-channel arrays-the object of inference is the change in expression of the assayed genes.
More specifically, we are interested in the comparison of expression values for N genes across two experimental conditions. We assume that the measurements come from cDNA-spotted microarrays (also variously referred to as slides or chips), but many of the methodological aspects translate directly to other types of experimental devices. For convenience, we introduce the vector parameter θ= (θ 1 , . . . ,θ N )
T , representing the true change in expression between two compared conditions of genes i = 1, . . . , N . Associating to each gene a single θ i is somewhat arbitrary as, even if we could measure it with no error, the expression change of a given gene will be different in each pair of cells. With θ i , then, we refer to an abstract population value that is differently realized in each pair. The nature of gene expression array experiments is such that, for any two cell conditions that are compared, one expects only a certain fraction of the genes on the screen to change expression. This is trivially true for the large number of genes that are expressed in neither of the two conditions. Moreover, the changes in experimental conditions experienced by the cells are such that they are expected to generate a relatively small number of changes; it would be of little scientific worth to compare radically dissimilar cellular conditions. In terms of the vector parameter θ, this amounts to the knowledge that a large portion of the θ i are effectively zero.
The data available to make inferences on the θ i are measurements of fluorescent intensity at discrete locations of a microarray, each location being associated with a specific gene i. The exact functional relationship between increases in expression and increases in intensity levels is not known, and the number of replicates for a given experiment is typically rather small. Given the outlined characteristics of the parameter of interest and the data available for inferential purposes, both the scientists generating the data and the statisticians analyzing it have found that the most fundamental use of array data is simply addressing the question of which genes experience a functional change in expression; that is, for which genes i does θ i = 0?
It appears to us that two areas of statistical methodology have emerged as particularly relevant in this context: empirical Bayes procedures and hypothesis testing with correction for multiple comparisons. Empirical Bayes procedures to analyze gene expression array data have been used by Newton et al. (2001) , Tseng et al. (2001) , Baldi and Long (2001) , Ibrahim et al. (2002) , Ishwaran and Rao (2003) , and others. Indeed, in a context where the number of observations per genes is typically very limited and the number of genes very large, empirical Bayes procedures that allow borrowing strength across genes appear to be a very effective tool to channel the little information available on a large number of genes.
Many researchers have focused on the problem in terms of hypothesis testing. Null hypotheses are taken to be H i :θ i = 0 for i = 1, . . . , N, and a test is performed for each hypothesis. It is immediately evident that for N on the order of thousands of genes, some sort of multiple comparisons correction must be undertaken, and microarrays have proven to be fertile ground for novel approaches. Resamplingbased procedures have been studied to control a variety of measures of global errors Dudoit et al., 2004) , the usefulness of measuring global error in terms of false discovery rate (FDR) has been argued, and multiple methods to estimate FDR, and local FDR, under a series of hypotheses on the test statistics have been proposed Storey and Tibshirani, 2003; Sabatti et al., 2003; Reiner et al., 2003) .
These two trusts of the statistical analysis of microarray experiments have also been combined. The work by , for example, provides an interpretation of the FDR criteria in terms of nonparametric empirical Bayes procedures. A sizeable proportion of the empirical Bayes papers, moreover, still focus on the problem of testing H i :θ i = 0 for i = 1, . . . , N, while often differing in how best to deal with the problem of multiple comparisons. Newton et al. (2001) , for example, define a Bayesian version of FDR control.
Certainly, a hypothesis testing framework allows one to consider θ i = 0 as a special and common value and deflects attention from estimating the precise value of θ i , which is often too difficult given the noise level in the data. By adopting this inferential framework, however, one buys into much more: type I error (and its family analogues) becomes the primary element of interest, in the sense that a false rejection of the null hypothesis H i :θ i = 0 is considered more serious than a false non-rejection. It is not clear to us that this is the appropriate emphasis in the context of microarrays. For one, microarray experiments are considered by the scientific community not as a means to test, but as instruments to generate, hypotheses;
that a gene appears up-regulated in a condition on the basis of microarray experiments is not taken as solid evidence for this to be the case, no matter how small the p-value nor how strong the estimated effect. Only when another experimental technique (such as in situ hybridization) is able to verify the change in expression is the hypothesis considered corroborated. And while it is clear that one does not want to try to replicate the change in expression of thousands of non-changing genes, one has to consider that the cost of investigating suspicious genes with other experimental techniques is not terribly high. On the other hand, the failure to identify from the thousand of genes in the screen the ones that change expression represents a very serious loss for the researcher. Based on this consideration, we think that other inferential frameworks may be more appropriate. In particular, we would like to point the reader's attention to three alternative approaches that are available to the statistician.
One can describe loss as the number of misclassifications, that is, the total number of false positives and false negatives, and choose a procedure aimed at minimizing that loss. This approach is rather straightforward in a Bayesian context but has not typically been explored in a frequentist setting, a recent exception being the work of Genovese and Wasserman (2002) . It is also possible to cast the question in a model selection framework, discussing which parameters θ i = 0 need to be introduced to maximize a criterion such as AIC, BIC, or MDL. The literature on model selection is extensive; particularly relevant for our setting is the work of Casella and George (1992) , George and McCulloch (1993) , who illustrate how to carry out model selection in a Bayesian setting using a Markov chain Monte Carlo (MCMC) algorithm to explore the posterior, and Ishwaran and Rao (2003) , who suggest using this framework for gene expression array analysis.
A third approach is to estimate θas a sparse vector, using the a priori knowledge that most of its elements are zero. This methodology has been developed primarily in the context of wavelet thresholding. There, the choice of an appropriate basis (as wavelets) has the effect of transforming the observations in a sparse vector that is known to have, on theoretical grounds, only a small number of non-zero components. Denoising of the original observations can be achieved by thresholding the coordinates of the transformed vector that are not significantly different from zero. Donoho and Johnstone (1994) provide an introduction to this area, and Abramovich et al. (1998) illustrate how to set up a Bayesian model for this framework.
All three of these approaches have theoretical links to each other and to the hypothesis testing framework. The manuscript by Abramovich et al. (2000) illustrates particularly well the connections between estimation of a sparse vector and tests of multiple hypotheses with corrections for multiple comparisons, exploring both Bonferroni-type and FDR procedures. In what follows, we will often refer to the FDR-thresholding estimator that is introduced in that paper; the Benjamini and Hochberg (1995) rule for controlling FDR at a level q is used to identify a hard threshold, with q playing the role of a tuning parameter. We will compare the results of this to our method. While they are both estimators for sparse mean vectors, practitioners accustomed to a multiple testing approach should find it easier to appreciate the characteristics of our Bayesian approach when comparing it with a procedure that is so closely related to a multiple testing one.
In this manuscript, we illustrate how the framework of estimation of sparse vectors can be applied to the microarray context. Our approach aims to estimate the entire vector θ, both identifying the zero components and denoising the remaining ones, thus providing the biologist with a rich set of information. Additionally, it offers a framework through which to understand and improve the thresholding rules that biologists typically use to analyze microarray data.
The remainder of the manuscript is organized as follows. Section 2 introduces a Bayesian framework to estimate sparse vectors by identifying appropriate priors and loss functions and describes the form of the estimator with a simple data model. Section 3 shows how the same principles can be applied to more general data models and introduces a hierarchical Bayes framework for the estimation of unknown parameters. Connections with FDR-thresholding procedures in the context of microarrays are explored using a simulation study. Section 4 presents the analysis of two actual datasets and illustrates how our inferential framework can be applied to general models for microarray data. We conclude with a summary and discussion of the main results.
Bayesian estimation of a sparse mean vector
We introduce into the Bayesian inferential framework the knowledge that the vector of parameters θis sparse by 1) defining a prior distribution on θthat gives substantial weight to the zero value and 2) selecting a loss function that penalizes non-sparse estimates. In particular, we specify:
where δ 0 is the Dirac delta function at zero. The prior distribution assumes independence between the θ i (conditional on p and ω) and assigns a positive probability to θ i = 0, which indicates that there is no functional change in expression for gene i between the baseline and experimental conditions. Notice that this translates, irrespective of the probability model linking the θ i to the observed data, to a posterior distribution of the θ i that also has point mass at zero. Mixture prior distributions of this nature are typically used in a Bayesian framework when researchers want to test a point hypothesis (Berger, 1985) . They have been used in regression variable selection (Mitchell and Beauchamp, 1988; George and McCulloch, 1993) and are becoming increasingly popular in microarray analysis (Newton et al., 2004; Ishwaran and Rao, 2003; Ibrahim et al., 2002) , although in these three papers the Bayesian model is used within a hypothesis testing framework. Abramovich et al. (1998) describe their use in conjunction with the 1 loss function in the context of wavelet coefficient denoising. We will initially review their model, in order to provide some insight to the nature of these assumptions. A crucial difference between the setting of Abramovich et al. and ours is that ultimately we do not assume ω known, while these authors do. In this respect, our prior assumptions are closer to those of Johnstone and Silverman (2004) , even if our data model differs substantially.
The proposed 1 loss function has the following notable characteristics: 1) it is a global loss (that is, the error is evaluated across all the θ i ) so that it naturally leads to a control of global error, and 2) being based on absolute rather than squared difference, it does not discount small errors, which are the ones most likely to be made when estimating a parameter that is truly equal to zero. Abramovich et al. state that 1 loss is the "natural measur[e] for spatially inhomogeneous functions"; to see why this is so, it is useful to observe how this loss function behaves with respect to sparsity. A vector with small 1 norm tends to be sparser than a vector with the same 2 norm. For example, the n-dimensional vector (1/n, . . . , 1/n) has 2 norm 1/ √ n, but 1 norm equal to 1. The 1 loss function, then, favors sparser error vectors and therefore behaves more like a misclassification rate than the 2 loss function does. Coupling this observation with the knowledge, embedded in our prior choice, that the parameter vector is likely to contain a sizeable number of zeroes, one gets an inferential procedure that tends to select zero as a point estimate when there is a substantial probability that this is the true value and hence no error is made. This is readily apparent if one considers what happens to Bayesian inference under this prior and loss function. Under 1 loss, Bayesian risk is minimized by choosing the posterior median, not mean, as the estimator for θ i . As stated above, the posterior distribution of each θ i will have mass at zero, and its median will be zero whenever this mass is larger than 1/2 or when the difference between the probabilities of the two tails is small enough. Under 2 loss, on the other hand, the Bayes estimator is the posterior mean and therefore will never equal zero. To make this point explicit and illustrate further properties, we consider a specific data model that was originally considered in Abramovich et al., mindful that it represents an oversimplification of microarray data.
Suppose that M slides are hybridized and the observed microarray data are represented by {y ik }, k = 1, . . . , M. These data are assumed (and will be for the rest of the paper) to be quality-controlled, channel-normalized, and log-transformed differences between experimental cells and control cells. Tseng et al. (2001) and Yang et al. (2002) describe rank-invariant normalization methods applicable to the experiments described here. Let us then assume that
where the ε ik iid ∼ N (0, π). Throughout this paper, Gaussian distributions are specified by their mean and precision, defined as the reciprocal of variance. Under these conditions, an analytical solution for the posterior median can be derived:
and ξ i is the posterior odds ratio for the component at 0, namely
.
This analytic expression allows us to point out some features of the 1 estimator. It is a continuous thresholding rule, with a thresholding level that depends on the noise variance, the sparsity level, and the precision of the Gaussian component of the prior. When θ i is not zero, it is a shrunk version of the data average. Figure 1 shows how the threshold changes under three different levels of noise variance.
With ω set to .05 and p set to 1, the noise variance 1/π is variously set at 1/4, 1/16, and 1/64. Asymptotically, the function approaches a slope of 1/(1 + (p/π)). The right-hand graph plots θ i as a function ofȳ i• √ π, which is the mean scaled by the standard deviation; it is clear that the threshold is not linear in the standard deviation 1/ √ π, although changes are minor. The relationship between noise variance, sparsity (defined as 1 − ω), and threshold is shown in greater detail in figure 2. In the left-hand plot, noise variance is held constant and the threshold is plotted as a function of sparsity. The threshold is highest for the most sparse data, while the threshold approaches zero for well-populated data.
We have already discussed at length the attractiveness of thresholding estimators in the context of gene expression array studies, underscoring how they lead to inferential results which reflect practitioners' beliefs on the nature of changes in transcription levels, in particular, that the change will be zero for a large proportion of genes. Thresholding estimators lead to a result that is also connected to the one of hypothesis testing. Abramovich et al. (2000) show how the universal threshold of Donoho and Johnstone (1994) can be related to a Bonferroni correction of Gaussian tests. In the same paper, the authors show how the thresholding estimator derived from FDR-controlling rules is, instead, adaptive to the unknown level of sparsity. Note that the Bayesian thresholding estimator presented above depends on the level of sparsity in the data, but so far this has been assumed known. In the following section, we will illustrate how it is possible to estimate the level of sparsity and obtain a thresholding estimator that is adaptive to unknown sparsity in a hierarchical Bayesian model. In this sense, one can take the approach we present as a descriptive explanation of the operational characteristics of FDR; the sparsity level is estimated from the data and used in the definition of a thresholding rule. For another connection between hierarchical Bayes models and FDR-thresholding procedures, see . 
Hierarchical Bayes and adaptive thresholding
In this section, we consider both a more realistic model for gene expression and less detailed prior knowledge. With regard to the data generating mechanism, there are a variety of models for gene expression that one may consider, and the inferential framework we are describing can be applied, with comparable implications, to any such model as long as it includes a population change-in-expression parameter θ. When presenting some data analysis results in the next section, for example, we will use the model proposed by Tseng et al. (2001) . For the time being, we intend to focus on basic properties of our Bayesian inferential framework and illustrate them with a comparative analysis. Our setting is as follows. The experiments involve N genes and M slides. We again assume that the observed expression value for gene i in slide k is distributed as
where ε ik ind ∼ N (0, π i ), with a different variance for each gene. On the noise precision π i we place a gamma prior with shape a i and rate b i , notated π i ∼ Gamma(a i , b i ). Notice that not only the π i but also the a i and b i are free to vary from gene to gene. The a i and b i are considered fixed and known, although in practice their values will be estimated from a separate set of calibration slides, in which mRNA extracted from comparable cells lines are oppositely dyed and hybridized to the same slide, or from the the comparison data y ik , or from a combination of both. Using the data y ik to estimate prior parameters follows an empirical Bayes paradigm. While we attempt to avoid overtapping the data, there are situations where using the data to estimate certain nuisance parameters is both appropriate and robust.
With regard to the prior assumptions, recall that we placed on θthe mixture prior (1), with hyperparameters p and ω. In the following discussion we assume a prior on p ∼ Gamma(α, β). In practice, one may actually prefer to choose one particular value for p based on existing data. The weight parameter ω receives a beta prior, ω ∼ Beta(c 0 , c 1 ). The hyperparameters α,β, c 0 , and c 1 are specified to yield diffuse, essentially noninformative, distributions. Figure 3 diagrams the described model, showing its hierarchical structure. For notational convenience, let z i = 1 (θ i =0) , indicating whether or not gene i experiences any expression change between experimental and control conditions. With this in mind, we can write an expression proportional to the joint posterior likelihood of the parameter set {ω, p, θ, π}:
Unlike what is illustrated in the previous section, it is not possible to derive an analytical expression for the posterior medians of θ i . We describe an MCMC routine for exploration of the posterior distributions. It is a collapsed Gibbs sampler (see Liu et al., 1994) based on the following conditional distributions:
where
Simulations
In order to explore the performance of our MCMC procedure and the characteristics of our inferential framework, we conducted a simulation study. To interpret results, it is useful to analyze the same simulated datasets with another procedure for benchmarking purposes. Given that FDR-thresholding procedures have been repeatedly proposed for the analysis of this type of dataset and that they are, like ours, adaptive to unknown sparsity, we decided to use them as our benchmark. In particular, because we wanted to compare the performance of the 1 estimator to those of another estimator (rather than a hypothesis testing procedure) we considered the following FDR-based thresholding estimator, as described in Abramovich et al. (2000) . We indicate with q the desired level of FDR, which represents a tuning parameter for this thresholding estimator. Let t i be the t-statistic corresponding to gene i, resulting in a p-value p i . We notate the ordered vector of p-values by (p (1) , . . . , p (N) ). Let k be the largest i for which p (i) < q(i/N ), and t k the corresponding t-statistic. Then the FDR-thresholding estimator of level q sets θ i = 0 if |t i |≤|t k |, otherwise θ i =ȳ. Note that this construction is based on the same ruled described by Benjamini and Hochberg, so that it should also be easy to compare the results of our procedure with one based on testing.
Each simulated data set is comprised of N = 1000 genes, with M = 4 slide replicates per gene. The degree of sparsity is specified by 1 − ω. Given ω, ωN randomly selected genes are assigned a non-zero θ i generated from N (0, 1), while for all other genes θ i = 0. In different simulations, ω varies among 0.01, 0.025, 0.05, 0.1, 0.15, and 0.25. Given the θ i , noise variance is added according to the hierarchical model. Namely, gene-specific precisions π i are generated from Gamma(a, b), where a = 2 and b varies among 1/10, 4/10, and 16/10 in different simulations, each increase in b representing a doubling of the average noise deviation (for brevity we will refer to these levels as baseline and multiples of it). For both the MCMC and FDR-thresholding procedures, a and b are considered fixed and known. Therefore, t-statistics for FDR thresholding are computed using an adjusted variance estimate incorporating the prior gamma distribution,
where σ 2 i is the usual variance estimate computed from the M = 4 data points for gene i. To compute p-values, the resulting t-statistics are compared to the t distribution with M − 1 + 2a degrees of freedom.
The nine plots in figure 4 compare the performance of the 1 estimator to FDR thresholding at q = 0.05 and q = 0.20, for simulations at the various levels of sparsity and noise variance. Each point on these plots represents an average of twenty independent simulations. The top row of plots shows mean absolute error. As noted before, the 1 statistic minimizes absolute error loss, so it is no surprise that 1 performs at least as well as the FDR-thresholding statistics in each case. The middle row shows the predicted proportion of zero-changers, that is, one minus the predicted sparsity. The dashed line at unity slope represents the true value. In every instance, each of the three statistics overestimates the proportion of zeroes, increasingly so as the level of noise variance increases. This is to be expected and not really a problem in terms of the interpretability of the results as, given our model for θ, some of the true changers have θ i very close to zero. At the lowest noise variance, the 1 estimator falls between the two FDR-thresholding procedures. As noise variance increases, however, FDR thresholding becomes increasingly conservative while 1 still discriminates between the different levels of sparsity.
The bottom row shows the actual proportion of false discoveries achieved by the three estimators. FDR thresholding does achieve its goal of staying under the two dotted lines at .05 and .20, respectively, whatever the sparsity. The 1 estimator, however, produces increasing values as the noise variance increases. Generally speaking, the 1 estimator seems to behave as an FDR-thresholding procedure that adaptively selects the tuning parameter q based on noise variance. (Note how the achieved FDR does not appear to vary across sparsity levels within a given noise Figure 4 : Performance of 1 estimator and FDR thresholding with q = 0.05 and 0.20. Each column corresponds to one noise level. In the three rows, from top to bottom, we plot mean absolute error, estimated proportion of zeros, and achieved FDR against a range of sparsity levels. Each point in the graph is the average of the results of 20 independent simulations corresponding to the indicated parameter settings. 
Data analysis and more realistic models of expression data
We now consider two datasets and present the results of their analysis with 1 estimation. The first example consists of a series of experiments aimed at elucidating the variation in gene expression resulting from suppressing transcription of a gene known to cause Friedreich's ataxia. The second dataset was collected with the explicit intention of studying the noise level of cDNA experiments and compares the expression values of genes in E. coli when cells are grown in two different media.
Friedreich's ataxia
Friedreich's ataxia is one of the most common forms of autosomal recessive ataxia in humans and is caused by reduced expression of the frataxin-producing gene on chromosome 9q13. Clinical features include progressive neurological, cardiovascular, skeletal, and endocrine abnormalities. The disease has been modeled in transgenic mice in which the expression of frataxin is reduced to 25%-36% of wild-type levels (while knocking out the entire gene, however, is lethal; Miranda et al., 2002) . The transgenic mice are phenotypically identical to wild types because of compensatory effect. In order to achieve a finer resolution of the phenotype, a study of the changes in expression levels for a large set of genes involved in brain function appears as a promising strategy. Indeed, the laboratory of professor Dan Geschwind is carrying out experiments along these lines (Choi et al., 2003) . We were involved in the analysis of one of the initial experiments in this study. A custom mouse cDNA microarray of roughly 10,000 genes was probed with cDNA from three brain regions (brain stem, cerebellum, and spinal cord) affected in Friedreich's ataxia, from each of four transgenic mice, two male and two female. Four wild-type mice served as controls, again two male and two female. The two male controls, however, were combined into a single male control, same with the female. Thus, although cells from the two male transgenic mice were hybridized to separate slides, they were compared to the same controls; likewise with the females. Each of the twelve comparisons, furthermore, were performed on a pair of dye-flipped slides, which were subsequently averaged to help control labeling bias. After data normalization and quality control, a data set consisting of 8,578 genes was produced for analysis.
The Friedreich's ataxia data are analyzed using the model described in the previous section. Initial analyses show that expression patterns vary significantly between brain regions, so the set of θ i is allowed to vary independently between each brain region. In other words, the data are analyzed with N not merely equal to 8,578 but 3 × 8,578 = 25,734. However, because the probe design is the same regardless of brain region, noise variances 1/π i are constrained not to vary from brain region to brain region. Thus π i = π i+8578 = π i+17156 for i = 1, . . . , 8578, and estimation of the π i benefits from a three-fold increase in readings per estimate.
In addition to the twelve dye-crossed pairs of comparison slides, a dye-crossed pair of calibration slides was produced in which cerebellar tissue from two transgenic mice was oppositely dyed and hybridized. Because both tissue donors are transgenic, θ i = 0 for all genes on the calibration slides, and therefore all variation is due to biological and measurement variance, which in the single-layer model is represented by the 1/π i .
Recall that the prior distributions on the π i are Gamma(a i , b i ). In this example, the limited amount of calibration data dictates that we constrain a i and b i to be constant between genes. If we represent the calibration data by x i , then viewing the distribution of the 1/x 2 i can help determine reasonable values for a and b. In this example, viewing a histogram of the 1/x 2 i led to setting a to 0.7 and b to 0.09. As we will show in the second empirical example, a larger complement of calibration data enables gene-specific estimation of one or both of these parameters.
A full complement of comparative data was not available for every gene, and restricting analysis to genes with complete data would have been excessively restrictive. Computation of conditional posteriors, therefore, required slight modification. For example, the conditional posterior distribution of π i is Gamma(
2 /2). If, for a given gene i, not all the y ik are available, then M is replaced by the number of populated y ik , and the summation in the rate parameter is only over those k for which y ik is populated.
We again wish to compare the 1 approach to FDR thresholding as a benchmark. The computation of t-statistics and p-values reflects the prior knowledge on noise variance gleaned from the calibration slides, and adjustments are directly analogous to those described in the simulation example. Figure 6 shows the distribution of p-values. On the left is a histogram of all p-values. The increased weight toward zero indicates the existence of differential expression in a significant number of genes. On the right-hand plot of ordered p-values, however, we see that FDR thresholding with values q = .05 and q = .30 results in estimating as zero the entire θvector. This is a somewhat disappointing result, as it appears to be biologically very reasonable to expect a change in the expression of some genes. Only by setting q to the unusually high value of 0.55 yields a reasonable number of genes, roughly 200, for which a value of θ i different from zero is estimated. Figure 7 , on the other hand, shows the 1 analysis of the spinal cord data. The plot exhibits a shrink-or-kill behavior that is roughly equivalent to that shown in the simpler example of figure 1. Deviations from a simple functional line are due to the gene-specific variance estimates. In other words, the plot can be seen as a random admixture of several of the plots shown in figure 1 . The 1 estimator identifies 240 genes with θ i = 0. The earlier simulations indicate that this number is probably a conservative estimate, even though roughly half of these genes are doomed to be false discoveries.
E. coli
We use the E. coli data analyzed in Tseng et al. (2001) as a second empirical example. In this experiment, E. coli cells were grown in contrasting growth media, namely glucose and acetate. There were E = 3 biological replicates, each of which was hybridized to R = 2 replicate slides. Additionally, there were four calibration slides, two of which compared acetate-grown to acetate-grown cells, and two of which compared glucose-grown to glucose-grown. Following channel normalization and quality filtering, a data set of N = 2291 genes was prepared for analysis. Given the structure of this dataset, it is possible and meaningful to introduce a more sophisticated model for expression values. In particular, we are going to use the same hierarchical data model adopted in Tseng et al., except using our mixture prior and 1 loss, and then compare our results to those obtained with the slightly different inferential framework of the original paper.
The hierarchical model explicitly differentiates between biological and measurement error sources of variance. Instead of simply referring to M replicates, Avg / StdDev
Posterior median E biological subjects are identified, with R slide replicates per subject, for a total of R × E observations per gene. Figure 8 diagrams the hierarchical structure of the model. For a given gene i, there are E unobserved subject-specific expression changes µ i1 , . . . , µ iE , with subjects indexed by l = 1, . . . , E. The prior distributions on the µ il are, as in the single-layer model, Gaussian with means θ i and variances 1/π i . Similarly, the priors on the precisions π i are gamma with shape and rate parameters allowed, in the most general form, to vary from gene to gene. For a given subject l and gene i, there are R observed expression changes y il1 , . . . , y ilR , with replicates indexed by k = 1, . . . , R. Given the subject-specific µ il , the priors on the y ilk are Gaussian with means µ il and variances 1/τ i . The priors on the precisions 1/τ i are again gamma with possibly gene-specific shapes A i and rates B i .
The collapsed Gibbs sampler procedure to explore the posterior obtained with this model is very similar to the one previously described. Below we provide the conditional distributions used in each step has to be repeated for each possible value Under this more complex model structure, we no longer use FDR thresholding as a benchmark, because it is unclear how a t-test would take advantage of the additional information yielded by the hierarchical structure and calibration data. Instead, we use as a benchmark the framework of Tseng et al., which is the same as the Bayes structure described above except for the prior distribution on θ. In their application, they place a flat, noninformative prior on the θ i , which leads to posteriors of θ i that have no point mass at zero.
Because the flat-prior posteriors place no special emphasis on zero-changers, there is no implicit Bayesian test of the hypothesis H i :θ i = 0. In Tseng et al., the authors report 95% confidence intervals for the θ i and identify a gene as up-or down-regulated when its confidence interval does not include zero. Figure 9 compares mixed-prior and flat-prior results. The graph plots the mixed-prior posterior median against a normalized within-gene average. We recognize the characteristic shape from earlier figures and note that deviations from a single functional line are due to across-gene variation in the posterior distributions of biological and slide variance. Genes whose flat-prior 99% confidence interval falls outside of zero are highlighted by crosses, while the 95% level is represented by triangles. Our analysis identifies 168 differentially expressed genes, which falls in between the 75 identified by flat-prior 99% CI and the 266 identified by flat-prior 95% CI. Figure 10 compares the two posteriors in a slightly different fashion. Posterior medians are again plotted on the vertical axis, but the horizontal axis is a simple data mean, meaning that non-zero points show more spread than in figure 9 . The vertical lines span 99% confidence intervals from the flat prior model, and we note that with the exception of only one gene at the far right, all posterior medians from the mixture prior fall within them. Confidence intervals that span zero are colored differently from those that remain above or below; this emphasizes that the 1 analysis selects more genes than selection based on the 99% CI, but fewer than one based on 95%, as shown in figure 9.
Discussion
We have described how to estimate the population expression change for genes surveyed in an array experiment, using a hierarchical Bayes framework under the assumption that a large number of such changes is effectively zero. Using an estimation approach deflects emphasis from type I error control. We argue that this is more appropriate for exploratory investigations whose aim is to identify genes that likely change expression across two cell lines characterized by expression differences.
Our simulation study is conducted under rather simplistic hypotheses on the Average / SD Mixed−prior posterior medianSignificant flat−prior 95% CI Significant flat−prior 99% CI nature of the noise in array experiments; it is not possible to extrapolate the performance of our estimator in that setting to actual array data. The characteristics of our procedure and its relation to FDR control which emerge from the simulation are, however, likely to be valid more generally. In particular, just as the 1 loss function is related to misclassification error, our estimates will tend to provide a low misclassification rate. This can be described as adaptively selecting a level for FDR control based on the signal-to-noise ratio. The Friedreich's ataxia data set provides an illustration of such advantage: despite a low number of replicates compared to the experimental noise level, we were able to provide a list of genes whose transcript levels likely change in the frataxindeficient mice. While a large number of false positives is to be expected, their proportion is selected to minimize a global loss, not determined by a researcher's arbitrary choice of a "reasonable" number of genes in the final list.
The E. coli data illustrate another advantage of the estimation procedure we suggest. The results from expression experiments are often used in further analyses, such as clustering or classification and regression procedures. In such cases, practitioners often summarize the results of replicate comparisons between two cell lines with their average. Using our procedure to provide this summary allows a better use of the information in the data set not only by borrowing strength across genes, but also by passing to further analysis the fact that a given gene appeared not to have any detectable change in expression across the two studied conditions. While we think that the description of array experiments we have provided correctly illustrates the majority of them, there are some cases where either considering θa sparse vector or the goal of the experiment merely exploratory is less appropriate. A striking example are the "subtraction arrays" described in Geschwind et al. (2001) ; in a first step, a subtraction technique is used to identify transcripts that appear to be more abundant in one of the two cell lines under study, while in a second step, the cDNA corresponding to these are spotted on an array and the amounts of their expression further quantified. In this situation, one clearly expects the majority of genes to change expression and the assumption of sparsity on θmay not be appropriate. Furthermore, the experiment has a less exploratory nature and tighter type I error control may be appropriate.
The estimation of sparse high-dimensional vectors is an important topic in contemporary statistics (Donoho and Johnstone, 1994; Abramovich et al., 1998 Abramovich et al., , 2000 Johnstone and Silverman, 2004) . The application that seems most often considered is the thresholding of wavelets coefficients, and interesting theoretical results are obtained in cases where specific assumptions on the noise structure are possible. The hierarchical Bayes framework presented here applies this methodology to a novel problem; in combination with the MCMC algorithm, it allows for considerable variation in distributional assumptions, of which only a couple are illustrated
